SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹30 Cr | ₹31 Cr | ₹0.40 Cr | ₹0.41 Cr | ₹0.50 Cr |
What is the latest Total Non-Current Liabilities ratio of SHREE GANESH REMEDIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹30 Cr |
Mar2023 | ₹31 Cr |
Mar2022 | ₹0.40 Cr |
Mar2021 | ₹0.41 Cr |
Mar2020 | ₹0.50 Cr |
How is Total Non-Current Liabilities of SHREE GANESH REMEDIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹30 Cr | -1.37 | |
Mar2023 | ₹31 Cr | 7,505.72 | |
Mar2022 | ₹0.40 Cr | -1.23 | |
Mar2021 | ₹0.41 Cr | -17.78 | |
Mar2020 | ₹0.50 Cr | - |
Compare Total Non-Current Liabilities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹1,040.2 Cr | 21.4% | 21.5% | 23% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 21.4% |
21.5% |
23% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses